Clinical Trial Update: Patient-Reported OUTcomes of Benralizumab in Real-World Use in Severe EosiNophilic Asthma Patients

View source ↗

Summary

This completed clinical trial update reports patient-reported outcomes for benralizumab used in real-world treatment of severe eosinophilic asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Eosinophilic Asthma

Drugs mentioned

• Benralizumab (benralizumab)

Snippet

Sponsor: AstraZeneca | Conditions: Severe Asthma | Status: COMPLETED